• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

7.470 +0.110 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 61,798
Open 7.330
Bid (Size) 7.020 (100)
Ask (Size) 7.950 (500)
Prev. Close 7.360
Today's Range 7.260 - 7.960
52wk Range 6.083 - 468.44
Shares Outstanding 833,683
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Publishes Preclinical Data Supporting TTX-MC138 for Glioblastoma
January 06, 2026
Via Investor Brand Network
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints Jack E. Stover to Board of Directors
December 22, 2025
Via Investor Brand Network

Performance

YTD
+0.9%
+0.9%
1 Month
-10.5%
-10.5%
3 Month
-38.9%
-38.9%
6 Month
-19.2%
-19.2%
1 Year
-92.4%
-92.4%

More News

Read More
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
December 11, 2025
Via Chartmill
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) and Quantum Leap Launch Collaboration to Evaluate TTX-MC138 in PRE-I-SPY Trial
December 11, 2025
Via Investor Brand Network
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints Dr. Michel Janicot as Senior Development Officer
November 17, 2025
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Completes Phase 1a Trial of TTX-MC138, Advancing to Phase 2 Evaluation
October 14, 2025
Via Investor Brand Network
News headline image
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
October 08, 2025
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Acquires Polynoma, Secures $25 Million Investment from CK Life Sciences to Advance Phase 2 Trial of TTX-MC138
October 08, 2025
Via Investor Brand Network
News headline image
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout ↗
October 08, 2025
Via Benzinga
News headline image
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset ↗
October 08, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 08, 2025
Via Benzinga
News headline image
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗
September 19, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
July 23, 2025
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
July 23, 2025
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
July 23, 2025
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
July 23, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
July 21, 2025
Via Benzinga
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
May 28, 2025
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
May 28, 2025
Via Investor Brand Network
News headline image
Which stocks are experiencing notable movement on Monday? ↗
May 19, 2025
Via Chartmill
News headline image
Top stock movements in today's session. ↗
May 19, 2025
Via Chartmill
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
May 08, 2025
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Sets 1-for-28 Reverse Stock Split Effective May 15
May 06, 2025
Via Investor Brand Network

Frequently Asked Questions

Is TransCode Therapeutics, Inc. - Common Stock publicly traded?
Yes, TransCode Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TransCode Therapeutics, Inc. - Common Stock trade on?
TransCode Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TransCode Therapeutics, Inc. - Common Stock?
The ticker symbol for TransCode Therapeutics, Inc. - Common Stock is RNAZ on the Nasdaq Stock Market
What is the current price of TransCode Therapeutics, Inc. - Common Stock?
The current price of TransCode Therapeutics, Inc. - Common Stock is 7.470
When was TransCode Therapeutics, Inc. - Common Stock last traded?
The last trade of TransCode Therapeutics, Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of TransCode Therapeutics, Inc. - Common Stock?
The market capitalization of TransCode Therapeutics, Inc. - Common Stock is 6.23M
How many shares of TransCode Therapeutics, Inc. - Common Stock are outstanding?
TransCode Therapeutics, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap